Zyprexa Follow-On Drugs Will Not Have Same Side Effect Profile As Atypicals, Lilly Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Zyprexa follow-on products will not be associated with the same adverse effects as the atypical antipsychotics, Lilly maintains during Bear Stearns health care conference in New York Sept. 14